Eucrates Biomedical Acquisition Corp.
EUCR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Market Cap | $29,760 | $29,075 | $135,264 |
| - Cash | $19 | $49 | $551 |
| + Debt | $60 | $0 | $0 |
| Enterprise Value | $29,801 | $29,026 | $134,713 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$2,576 | -$5,275 | $9 |
| % Margin | – | – | – |
| Net Income | $5,538 | $3,824 | $9 |
| % Margin | – | – | – |
| EPS Diluted | 1.86 | 0.28 | 0.001 |
| % Growth | 564.3% | 46,566.7% | – |
| Operating Cash Flow | -$630 | -$502 | – |
| Capital Expenditures | $0 | $0 | – |
| Free Cash Flow | -$630 | -$502 | – |